Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001641172-25-005107

Options or other derivatives

  • Chief Executive Officer acquired 409,992 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bagai Shaun Chief Executive Officer 2025-04-14 Grant or award · Stock Option +409,992 409,992 D
Loading xslF345X05/ownership.xml…